Ratiopharm Acquisition Catapults Teva to Lead European Generics Market
By PharmaDeals Analyst
Pharma Deals Review: Vol 2010 Issue 3 (Table of Contents)
Published: 1 Apr-2010
DOI: 10.3833/pdr.v2010.i3.1326 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Teva Pharmaceutical Industries succeeded in finally buying Ratiopharm, Germany’s second largest generics producer from the beleaguered Merckle Group...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS